Blexit - Indications: malignant neoplasms
should be considered a palliative treatment. It has been shown to be useful in the management of the following neoplasms either as a single agent or in proven combinations with other approved chemotherapeutic agents:Squamous Cell CarcinomaHead and neck (including mouth, tongue, tonsil, nasopharynx, oropharynx, sinus, palate, lip, buccal mucosa, gingivae, epiglottis, skin, larynx), penis, cervix, and vulva. The response to Blenoxane is poorer in patients with previously irradiated head and neck cancer. LymphomasHodgkin’s Disease, non-Hodgkin’s lymphoma. Testicular CarcinomaEmbryonal cell, choriocarcinoma, and teratocarcinoma. Blenoxane has also been shown to be useful in the management of:Malignant Pleural EffusionBlenoxane is effective as a sclerosing agent for the treatment of malignant pleural effusion and prevention of recurrent pleural effusions.